03/21/2021
Neuro‐axial steroid injection in pain management and COVID‐19 vaccine
Silviu Brill Uri Hochberg Itay Goor‐Aryeh
First published: 10 February 2021
https://doi.org/10.1002/ejp.1749
"In order to manage the risks of the interaction between the steroids and the vaccine, a new set of guidelines was recently developed within our Pain Institute. First, patients are warned of the immunosuppression risks of CSIs and are advised not to receive steroid injections during the 5‐week period beginning 1‐week prior to the first dose of the vaccine until 1‐week after the second dose. Second, in the cases where the patient, after being informed about the risks, insists on receiving an injection, dexamethasone is used. Dexamethasone has been shown to have a shorter duration of systemic effect and is, therefore, favoured over other steroids in these circumstances.
We believe that these guidelines provide sound advice to physicians performing CSIs as part of their treatment plan and are highly relevant as a worldwide effort to mass vaccinate come into effect."
Click on the article title to read more.